跳至主要内容
临床试验/CTRI/2025/11/097071
CTRI/2025/11/097071尚未招募3 期

Effect of Shashankalekhadi Leha And Jivantyadi Lepa As Described In Ashtang Hridayam For The Management Of Ek Kustha W.S.R. To Psoriasis A Clinical Study

Govt Ayurveda College Nipaniya Rewa MP1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年4月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
improvement in subjective parameters like Itching Sweating Erythema Eruption

研究概览

简要总结

TITLE  EFFECT OF SHASHANKALEKHADI LEHA AND JIVANTYADI LEPA AS DESCRIBED IN ASHTANG HRIDAYAM FOR THE MANAGEMENT OF EK-KUSTHA W.S.R. TO PSORIASIS   A CLINICAL STUDY

 In Ayurveda all skin disorders are classified under Kustha, which arises from the aggravation of TridoshasEk Kustha a type of Kshudra Kustha is mainly caused by the vitiation of Vata and Kapha doshas and closely resembles psoriasis   a chronic autoimmune skin disease characterized by erythematous scaly plaques on areas like the elbows knees and scalp

Samprapti Due to Nidana sevan  Tridosha become vitiated and cause shithilatain Twak Rakta Mamsaand Ambu dhatus resulting in the manifestation of Ek Kustha

Symptoms Rashes  dryness  fissures  scaling  itching redness and joint stiffness are common

Need for Research Psoriasis affects 0.44 to 2.8 of Indians, more common in males. The disease has significant psychological impacts including depression and suicidal tendencies  Conventional treatments like steroids and immunosuppressants have long-term side effects creating a need for safe and effective Ayurvedic alternatives

Study Design An openlabeled  single arm prospective clinical trial on 30 patients for 30 days with a 2 month followup

Patients aged 16 to 70 years were selected based on Ayurvedic diagnostic criteria

Exclusion Criteria Pregnancy  systemic diseases chronic cases over 5 years  psoriatic arthritis  or those unwilling to continue were excluded

Probable Mode of Action

Shashankalekhadi Leha

Contains Bakuchi Vidanga Pippali Chitraka Amalaki and Mandoor BhasmBalances Vata and Kapha dosha

Amalaki and Mandoor Bhasma reduce inflammation, act as antioxidants, and have Rasayana and Kushtaghna effects

Bakuchi’s psoralen compounds inhibit epidermal proliferation and modulate immune activity

Jivantayadi Lepa

Contains Jivanti Manjistha Daru Haridra Kampillaka Madar Tutha Sarjarasaand Madhuchista

Reduces itching redness and dryness

Possesses antiinflammatory, antibacterial  woundhealing and Kushtaghna properties

TREATMENT REGIMEN

 Drug                                               SHASHANKALEKHADI LEHA                                                       JIVANTYADI LEPA

 Form                                                          Leha                                                                                           lepa

 Dose                                                         3gm BD                                                                                     ¼ anguli

 Route of Administration                              Oral                                                                                          Local application

 Time of Administration                     Morning and evening                                                                         Morning and evening

 Treatment Course                                     30 days                                                                                              30 days

 Follow up                                                   2 months                                                                                       2 months

 Anupan                                                       Til Taila

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Ek kustha patient which will diagnosed as per the criteria Patient willing to sign consent from for trial.

排除标准

  • Pregnant and lactating women Systemic Disorders as Diabetic patients cardiac problem paralysis malignancy HIV leprosy Below 16years and above 70year Patients are excluded Patient who will under going in any surgery Disease chronicity more than 5 year Patients suffering from psoriatic Arthritis.

结局指标

主要结局

improvement in subjective parameters like Itching Sweating Erythema Eruption

时间窗: ON 0 DAYS TO 30 DAYS

次要结局

  • improvement in subjective parameters like Itching Sweating Erythema Eruption(ON 0 DAYS TO 30 DAYS)

研究者

发起方
Govt Ayurveda College Nipaniya Rewa MP
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

DR ROHIT

Govt Ayurveda College Nipaniya Rewa MP

研究点 (1)

Loading locations...

相似试验